Redeye is surprised and a bit concerned by Acuvi’s decision to replace its CEO. Particularly as the company seems to have good business momentum including several major orders announced lately. The Q3 report showed progress and was almost in line with our expectations. Our valuation is primarily impacted by rating changes and a higher WACC

Read more and download the Research Update.

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking.

Attachments

Acuvi - Looking for a new Captain

© Modular Finance, source Nordic Press Releases